ReviewJournal of clinical medicine2025
The Role of Megakaryocyte Assessment in Bone Marrow Cytology.
Review in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- An open bone marrow megakaryocyte dataset for automated morphologic studies.Scientific data · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite the progress made in recent years in hematological diagnostics, cytological assessment of bone marrow, including the assessment of megakaryocytes, is still an important element of the diagnostic process. It is one of the most accurate methods for detecting even minor abnormalities, which is often superior to histopathological examination in this respect. Although, according to current recommendations, megakaryocytes are not included in the total percentage formula of the myelogram, the assessment of platelet function, morphological features, and quantitative disorders allows for the direction of further diagnostic process. In this article, we present the principles of assessing megakaryocytes in a bone marrow aspirate smear. We also characterize normal megakaryocytes at various stages of megakaryopoiesis, atypical megakaryocytes in pathological and physiological conditions, and cells with a similar morphology to megakaryocytes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.